Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAX-interacting protein 1 (PAXIP1) is a nuclear protein characterized by six BRCT domains and encoded by the PAXIP1 gene. It is crucial for the maintenance of genome stability, chromatin condensation, and proper progression through mitosis[1][3]. PAXIP1 acts as a cofactor in histone H3 lysine 4 trimethylation via association with the MLL3/4 methyltransferase complexes and links these chromatin-modifying enzymes to gene promoters through direct or indirect interaction with DNA-bound transcription factors, such as members of the paired box (PAX) family[2][3][4][6]. PAXIP1 is involved in DNA double-strand break repair, functioning in both DNA damage signaling and homologous recombination repair pathways, and is required for effective post-irradiation cell survival[3][4]. In lymphocytes, PAXIP1 specifically regulates RAG-mediated chromatin remodeling, cleavage and repair during V(D)J recombination essential for T cell development and immunoglobulin class switching[2]. Loss of PAXIP1 impacts the transcriptional activation of immune-related genes such as sphingosine-1-phosphate receptor 1 (S1PR1), impinging on mature T cell egress from the thymus[2]. PAXIP1 is also implicated as a disease gene in neurodevelopmental and neurodegenerative disorders, including roles in Alzheimer's disease and rare genetic syndromes[1][3]. No known drugs directly target PAXIP1, and it is not currently considered a direct therapeutic target or biomarker[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAX-interacting protein 1 (PAXIP1).